Industry Focus
Healthcare: MannKind's Back from the Brink
- Autor: Vários
- Narrador: Vários
- Editor: Podcast
- Duración: 0:27:32
- Mas informaciones
Informações:
Sinopsis
A new cash lifeline from United Therapeutics buys the diabetes drugmaker more time to increase sales of its inhaled insulin. Also, make-or-break news is fast approaching for cardiovascular drugmaker, Amarin. MNKD, UTHR, AMRN
